We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$671M
AUM Growth
+$60.4M
Cap. Flow
+$46.4M
Cap. Flow %
6.91%
Top 10 Hldgs %
18.26%
Holding
913
New
123
Increased
382
Reduced
229
Closed
79

Sector Composition

Rank Sector Weight
1 Real Estate 10.08%
2 Financials 9.97%
3 Healthcare 9.71%
4 Consumer Discretionary 9.13%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOS
751
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$65K 0.01%
+11,883
New +$77.4K
AST
752
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$64K 0.01%
15,000
-4,500
-23% -$14.6K
APPS icon
753
Digital Turbine
APPS
$1.02B
$62K 0.01%
59,270
-28,550
-33% -$33.1K
VALE icon
754
Vale
VALE
$62.9B
$62K 0.01%
11,312
-1,316
-10% -$7.22K
ZNGA
755
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$61K 0.01%
21,106
-2,153
-9% -$6K
MNTX
756
DELISTED
Manitex International, Inc.
MNTX
$60K 0.01%
10,858
OIL
757
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
$60K 0.01%
10,310
-17,650
-63% -$99.4K
CCM
758
Concord Medical Services
CCM
$18.7M
$59K 0.01%
1,470
+91
+7% +$3.82K
GNCA
759
DELISTED
Genocea Biosciences, Inc.
GNCA
$59K 0.01%
1,429
+63
+5% +$2.47K
ABUS icon
760
Arbutus Biopharma
ABUS
$865M
$58K 0.01%
16,845
+4,845
+40% +$18.9K
AFMD
761
DELISTED
Affimed
AFMD
$58K 0.01%
2,074
+761
+58% +$21.3K
JRJC
762
DELISTED
China Finance Online Co., Ltd.
JRJC
$58K 0.01%
1,350
HSTO
763
DELISTED
Histogen Inc. Common Stock
HSTO
$57K 0.01%
143
+53
+59% +$21.6K
ZVRA icon
764
Zevra Therapeutics
ZVRA
$563M
$56K 0.01%
781
+62
+9% +$4.41K
LIME
765
DELISTED
LIME ENERGY CO.NEW COMMON STOCK
LIME
$54K 0.01%
25,862
+7,927
+44% +$16.9K
SPPI
766
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$53K 0.01%
+11,400
New +$67.5K
IMGN
767
DELISTED
Immunogen Inc
IMGN
$51K 0.01%
19,136
+6,470
+51% +$18.8K
NSLR
768
Neostellar Capital Corp
NSLR
$262M
$48K 0.01%
12,145
PPP
769
DELISTED
Primero Mining Corp
PPP
$48K 0.01%
29,045
+11,370
+64% +$21.8K
CALA
770
DELISTED
Calithera Biosciences, Inc
CALA
$47K 0.01%
725
+150
+26% +$9.67K
RAS
771
DELISTED
RAIT Financial Trust
RAS
$46K 0.01%
13,672
+1,178
+9% +$3.69K
SRRA
772
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$44K 0.01%
608
+187
+44% +$14.5K
LRMR icon
773
Larimar Therapeutics
LRMR
$416M
$43K 0.01%
+1,075
New +$48.8K
NOG icon
774
Northern Oil and Gas
NOG
$2.3B
$43K 0.01%
+1,600
New +$58.5K
WSCI
775
DELISTED
WSI Industries Inc
WSCI
$43K 0.01%
11,650
-3,050
-21% -$10.1K

Similar funds

Wedbush Securities's Q3 2016 Portfolio in Review

As of Q3 2016, Wedbush Securities held 913 positions worth $671M, up 9.9% from $611M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Wedbush Securities deployed $46.4M of net new capital in Q3 2016, opening 123 new positions and adding to 382 existing holdings. Its largest new stake was Triton International Limited: 92,729 shares worth $1.22M.

By sector, the portfolio is most concentrated in Real Estate at 10% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $1.06M trimmed.

  • Wedbush Securities's largest Q3 2016 buy was Triton International Limited: 92,729 shares worth $1.22M.
  • Wedbush Securities added most to Bristol-Myers Squibb in Q3 2016, an estimated $2.42M increase.
  • Wedbush Securities's biggest Q3 2016 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $1.06M.
  • Wedbush Securities fully exited TAL INTERNATIONAL GROUP, INC. in Q3 2016, selling an estimated $1.44M.
  • Wedbush Securities's ten largest holdings make up 18% of its $671M portfolio in Q3 2016.
  • Wedbush Securities opened 123 new positions and closed 79 in Q3 2016.
  • Wedbush Securities's portfolio value rose 9.9% quarter-over-quarter to $671M.

Based on Wedbush Securities's 13F filing for Q3 2016, filed 4 Nov 2016.